Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

GmMAX3b gene in soybeans boosts nodulation and affects hormone levels.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.